Youth and adult understanding of public displays of information about harmful constituents in cigarette smoke.

Samantha J Venrick, Katherine A Margolis, Jennifer K Bernat, Jessica K Pepper, James M Nonnemaker, Matthew E Eggers

Open access · greenAbstract readRandomized Controlled Trial

In one paragraph

Trial report in Preventive medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.4field-weighted citation impact, top 42% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

U.S. healthcare provider risk perceptions of tobacco and nicotine-containing products.Internal and emergency medicine · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Samantha J VenrickCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD, USA. Electronic address: Samantha.Venrick@fda.hhs.gov.

Katherine A MargolisCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Jennifer K BernatCenter for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Jessica K PepperRTI International, Research Triangle Park, NC, USA.

James M NonnemakerRTI International, Research Triangle Park, NC, USA.

Matthew E EggersRTI International, Research Triangle Park, NC, USA.

RTI International · USUnited States Food and Drug Administration · US

Funding

Intramural FDA HHS FD999999

6 · The paper itself

Abstract

The U.S. FDA is required by law to publicly display a list of harmful and potentially harmful constituents (HPHCs) "by brand and by quantity in each brand and subbrand" in a format that is "understandable and not misleading to a lay person." An online experiment examined youth and adult understanding of which HPHCs are present in cigarette smoke, understanding of health effects of smoking cigarettes, and endorsement of misleading information after viewing HPHC information displayed in one of six formats. We recruited youth (N = 1324) and adults (N = 2904) from an online panel and randomized them to one of six formats of presenting HPHC information. Participants responded to survey items before and after exposure to an HPHC format. Understanding of HPHCs in cigarette smoke and understanding of health effects of cigarette smoking significantly increased pre- to post-exposure for all formats. Respondents (20.6% to 73.5%) endorsed misleading beliefs after exposure to information about HPHCs. Endorsement of the one misleading belief that was measured pre- and post-exposure significantly increased for viewers of four formats. All formats increased understanding of HPHCs in cigarette smoke and the health effects of smoking cigarettes, but some participants endorsed each misleading belief after exposure to HPHC information.

Indexed as

Cigarette SmokingTobacco ProductsAdolescentAdultHumansSmokingCigarettesHarmful and potentially harmful constituentsMisleadingnessUnderstanding

Identifiers

PMID36813248

DOI10.1016/j.ypmed.2023.107458

PMCPMC10023421

OpenAlexW4321369236

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.